Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
THURSDAY, Jan. 12, 2023 -- For patients with mild-to-moderate COVID-19, treatment with fluvoxamine does not improve time to sustained recovery versus placebo, according to a study published online Jan. 12 in Journal of the American Medical...
Read more »